These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 31908689
1. Gonadotropin versus Follicle-Stimulating Hormone for Ovarian Response in Patients Undergoing in vitro Fertilization: A Retrospective Cohort Comparison. Ji Z, Quan X, Lan Y, Zhao M, Tian X, Yang X. Curr Ther Res Clin Exp; 2020; 92():100572. PubMed ID: 31908689 [Abstract] [Full Text] [Related]
4. The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles. Yang C, Dong N, Li F, Ji Y, Pan Y, She H. J Ovarian Res; 2022 Jun 21; 15(1):74. PubMed ID: 35729654 [Abstract] [Full Text] [Related]
5. Clinical outcomes following long GnRHa ovarian stimulation with highly purified human menopausal gonadotropin plus rFSH or rFSH in patients undergoing in vitro fertilization-embryo transfer: a multi-center randomized controlled trial. Shu L, Xu Q, Meng Q, Dai X, Zhang Y, Zhou W, Yi H, Liu J, Wu C, Hou Z, Cui Y, Li TC, Liu J. Ann Transl Med; 2019 Apr 21; 7(7):146. PubMed ID: 31157267 [Abstract] [Full Text] [Related]
6. In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review. Trew GH, Brown AP, Gillard S, Blackmore S, Clewlow C, O'Donohoe P, Wasiak R. Reprod Biol Endocrinol; 2010 Nov 08; 8():137. PubMed ID: 21059191 [Abstract] [Full Text] [Related]
8. Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial. Ye H, Huang G, Pei L, Zeng P, Luo X. Gynecol Endocrinol; 2012 Jul 08; 28(7):540-4. PubMed ID: 22390186 [Abstract] [Full Text] [Related]
9. Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH antagonist controlled ovarian stimulation protocol for patients undergoing assisted reproduction. Souza PMG, Carvalho BR, Nakagawa HM, Rassi TRE, Barbosa ACP, Silva AA. JBRA Assist Reprod; 2017 Jun 01; 21(2):67-69. PubMed ID: 28609269 [Abstract] [Full Text] [Related]
13. A pilot study comparing corifollitropin alfa associated with hp-HMG versus high dose rFSH antagonist protocols for ovarian stimulation in poor responders. Mendret-Pellerin S, Leperlier F, Reignier A, Lefebvre T, Barrière P, Fréour T. Hum Fertil (Camb); 2020 Jun 01; 23(2):93-100. PubMed ID: 30129813 [Abstract] [Full Text] [Related]
17. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles. Van Wely M, Westergaard LG, Bossuyt PM, Van der Veen F. Cochrane Database Syst Rev; 2003 Jun 01; (1):CD003973. PubMed ID: 12535497 [Abstract] [Full Text] [Related]
18. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age. Liao CC, Lee RK, Lin SY, Lin MH, Hwu YM. Taiwan J Obstet Gynecol; 2016 Apr 01; 55(2):239-43. PubMed ID: 27125408 [Abstract] [Full Text] [Related]
20. The influence of gonadotropins on clinico-biological ICSI outcome: a retrospective comparative study rFsH vs HP-hmg. Khlifi A, Kacem O, Maroueni M, Elgoul L, Hidar S, Fekih M, Boughizane S, Essaidi H, Ben Regaya L, Bibi M, Ajina M, Khairi H. Tunis Med; 2016 Jun 01; 94(6):167-177. PubMed ID: 28051220 [Abstract] [Full Text] [Related] Page: [Next] [New Search]